Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Tristetraprolin (TTP) Plasmid Vectors for Human and Mouse TTP
Case ID:
TAB-2975
Web Published:
12/6/2022
Tristetraprolin (TTP) is involved in the physiological regulation of the secretion of at least two important cytokines, tumor necrosis factor alpha (TNF) and granulocyte-macrophage colony-stimulating factor (GM-CSF). TTP exerts its effects by directly binding to the mRNAs encoding these proteins and destabilizing them, resulting in less secretion. Conversely, TTP deficiency results in an excess of both cytokines, leading to a systemic inflammatory syndrome. This invention include three categories of reagents related to TTP:1) Plasmid DNAs and mammalian expression vectors for human and mouse TTP; 2) Antibodies (rabbit antisera) to human and mouse TTP; 3) Immortalized macrophage cell lines derived from TTP-deficient mice and their wild-type littermates.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Tristetraprolin_(TTP)_Plasmi d_Vectors_for_Human_and_Mouse_TTP
Keywords:
Human
Listed LPM Wong as of 4/15/2015
Mouse
PLASMID
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
Tristetraprolin
TTP
vectors
Bookmark this page
Download as PDF
For Information, Contact:
Vidita Choudhry
Technology Development Specialist
NIH Technology Transfer
301-594-4095
vidita.choudhry@nih.gov